• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

IHGA:一个用于大规模全面发现肝细胞癌中感兴趣基因的交互式网络服务器。

IHGA: An interactive web server for large-scale and comprehensive discovery of genes of interest in hepatocellular carcinoma.

作者信息

Zhang Qiangnu, Hu Weibin, Xiong Lingfeng, Wen Jin, Wei Teng, Yan Lesen, Liu Quan, Zhu Siqi, Bai Yu, Zeng Yuandi, Yin Zexin, Yang Jilin, Zhang Wenjian, Wu Meilong, Zhang Yusen, Peng Gongze, Bao Shiyun, Liu Liping

机构信息

Division of Hepatobiliary and Pancreas Surgery, Department of General Surgery, Shenzhen People's Hospital (The Second Clinical Medical College, Jinan University, The First Affiliated Hospital, Southern University of Science and Technology), 518020 Shenzhen, China.

Integrated Chinese and Western Medicine Postdoctoral Research Station, Jinan University, 510632 Guangzhou, China.

出版信息

Comput Struct Biotechnol J. 2023 Aug 6;21:3987-3998. doi: 10.1016/j.csbj.2023.08.003. eCollection 2023.

DOI:10.1016/j.csbj.2023.08.003
PMID:37635767
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10457689/
Abstract

Mining gene expression data is valuable for discovering novel biomarkers and therapeutic targets in hepatocellular carcinoma (HCC). Although emerging data mining tools are available for pan-cancer-related gene data analysis, few tools are dedicated to HCC. Moreover, tools specifically designed for HCC have restrictions such as small data scale and limited functionality. Therefore, we developed IHGA, a new interactive web server for discovering genes of interest in HCC on a large-scale and comprehensive basis. Integrative HCC Gene Analysis (IHGA) contains over 100 independent HCC patient-derived datasets (with over 10,000 tissue samples) and more than 90 cell models. IHGA allows users to conduct a series of large-scale and comprehensive analyses and data visualizations based on gene mRNA levels, including expression comparison, correlation analysis, clinical characteristics analysis, survival analysis, immune system interaction analysis, and drug sensitivity analysis. This method notably enhanced the richness of clinical data in IHGA. Additionally, IHGA integrates artificial intelligence (AI)-assisted gene screening based on natural language models. IHGA is free, user-friendly, and can effectively reduce time spent during data collection, organization, and analysis. In conclusion, IHGA is competitive in terms of data scale, data diversity, and functionality. It effectively alleviates the obstacles caused by HCC heterogeneity to data mining work and helps advance research on the molecular mechanisms of HCC.

摘要

挖掘基因表达数据对于发现肝细胞癌(HCC)的新型生物标志物和治疗靶点具有重要价值。尽管有新兴的数据挖掘工具可用于泛癌相关基因数据分析,但专门针对HCC的工具却很少。此外,专门为HCC设计的工具存在数据规模小和功能有限等限制。因此,我们开发了IHGA,这是一个新的交互式网络服务器,用于大规模、全面地发现HCC中感兴趣的基因。综合HCC基因分析(IHGA)包含100多个独立的HCC患者来源数据集(超过10,000个组织样本)和90多个细胞模型。IHGA允许用户基于基因mRNA水平进行一系列大规模、全面的分析和数据可视化,包括表达比较、相关性分析、临床特征分析、生存分析、免疫系统相互作用分析和药物敏感性分析。这种方法显著提高了IHGA中临床数据的丰富度。此外,IHGA整合了基于自然语言模型的人工智能(AI)辅助基因筛选。IHGA免费、用户友好,能有效减少数据收集、整理和分析过程中花费的时间。总之,IHGA在数据规模、数据多样性和功能方面具有竞争力。它有效缓解了HCC异质性给数据挖掘工作带来的障碍,有助于推动HCC分子机制的研究。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2eaf/10457689/d91cae5ba286/gr8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2eaf/10457689/79f2e5376ccc/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2eaf/10457689/ac59bbf2b0f2/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2eaf/10457689/f4621d6a3e3c/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2eaf/10457689/90d7a8327614/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2eaf/10457689/c4351a66f2ab/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2eaf/10457689/bf6b12834eed/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2eaf/10457689/e9793e3121ed/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2eaf/10457689/d91cae5ba286/gr8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2eaf/10457689/79f2e5376ccc/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2eaf/10457689/ac59bbf2b0f2/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2eaf/10457689/f4621d6a3e3c/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2eaf/10457689/90d7a8327614/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2eaf/10457689/c4351a66f2ab/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2eaf/10457689/bf6b12834eed/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2eaf/10457689/e9793e3121ed/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2eaf/10457689/d91cae5ba286/gr8.jpg

相似文献

1
IHGA: An interactive web server for large-scale and comprehensive discovery of genes of interest in hepatocellular carcinoma.IHGA:一个用于大规模全面发现肝细胞癌中感兴趣基因的交互式网络服务器。
Comput Struct Biotechnol J. 2023 Aug 6;21:3987-3998. doi: 10.1016/j.csbj.2023.08.003. eCollection 2023.
2
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
3
Comprehensive Pan-Cancer Genomic Analysis Reveals PHF19 as a Carcinogenic Indicator Related to Immune Infiltration and Prognosis of Hepatocellular Carcinoma.全面泛癌基因组分析揭示 PHF19 作为一种致癌标志物与肝细胞癌的免疫浸润和预后相关。
Front Immunol. 2022 Jan 5;12:781087. doi: 10.3389/fimmu.2021.781087. eCollection 2021.
4
Identification and Characterization of Genes Related to the Prognosis of Hepatocellular Carcinoma Based on Single-Cell Sequencing.基于单细胞测序的肝细胞癌预后相关基因的鉴定和特征分析。
Pathol Oncol Res. 2022 Aug 25;28:1610199. doi: 10.3389/pore.2022.1610199. eCollection 2022.
5
Data mining of key genes expression in hepatocellular carcinoma: novel potential biomarkers of diagnosis prognosis or progression.肝细胞癌关键基因表达的数据分析:新的潜在诊断预后或进展的生物标志物。
Clin Exp Metastasis. 2022 Aug;39(4):589-602. doi: 10.1007/s10585-022-10164-9. Epub 2022 Apr 16.
6
Identification of Potentially Therapeutic Target Genes of Hepatocellular Carcinoma.肝细胞癌潜在治疗靶点的鉴定。
Int J Environ Res Public Health. 2020 Feb 7;17(3):1053. doi: 10.3390/ijerph17031053.
7
Screening of significant biomarkers with poor prognosis in hepatocellular carcinoma via bioinformatics analysis.通过生物信息学分析筛选肝细胞癌预后不良的显著生物标志物。
Medicine (Baltimore). 2020 Aug 7;99(32):e21702. doi: 10.1097/MD.0000000000021702.
8
High expression of PDZ-binding kinase is correlated with poor prognosis and immune infiltrates in hepatocellular carcinoma.PDZ 结合激酶高表达与肝癌预后不良和免疫浸润相关。
World J Surg Oncol. 2022 Jan 22;20(1):22. doi: 10.1186/s12957-021-02479-w.
9
Microarray Data Mining and Preliminary Bioinformatics Analysis of Hepatitis D Virus-Associated Hepatocellular Carcinoma.微阵列数据分析与丙型肝炎病毒相关性肝细胞癌的初步生物信息学分析。
Biomed Res Int. 2021 Jan 30;2021:1093702. doi: 10.1155/2021/1093702. eCollection 2021.
10
Comprehensive analyses of competing endogenous RNA networks reveal potential biomarkers for predicting hepatocellular carcinoma recurrence.综合分析竞争内源性 RNA 网络揭示了预测肝细胞癌复发的潜在生物标志物。
BMC Cancer. 2021 Apr 20;21(1):436. doi: 10.1186/s12885-021-08173-0.

引用本文的文献

1
Migrasome Marker Epidermal Growth Factor Domain-Specific -GlcNAc Transferase: Pan-Cancer Angiogenesis Biomarker and the Potential Role of circ_0058189/miR-130a-3p/EOGT Axis in Hepatocellular Carcinoma Progression and Sorafenib Resistance.迁移小体标志物表皮生长因子结构域特异性β-N-乙酰氨基葡萄糖转移酶:泛癌血管生成生物标志物以及circ_0058189/miR-130a-3p/EOGT轴在肝细胞癌进展和索拉非尼耐药中的潜在作用
Biomedicines. 2025 Mar 22;13(4):773. doi: 10.3390/biomedicines13040773.

本文引用的文献

1
Comprehensive bioinformatics analysis of a RBM family-based prognostic signature with experiment validation in hepatocellular carcinoma.基于 RBM 家族的预后特征的综合生物信息学分析,并在肝细胞癌中进行实验验证。
J Cancer Res Clin Oncol. 2023 Oct;149(13):11891-11905. doi: 10.1007/s00432-023-05084-4. Epub 2023 Jul 6.
2
Integrative analysis of lactylation-related genes and establishment of a novel prognostic signature for hepatocellular carcinoma.乳酰化相关基因的综合分析及建立用于肝细胞癌的新型预后标志物。
J Cancer Res Clin Oncol. 2023 Oct;149(13):11517-11530. doi: 10.1007/s00432-023-04947-0. Epub 2023 Jul 3.
3
Comprehensive analysis of KLF2 as a prognostic biomarker associated with fibrosis and immune infiltration in advanced hepatocellular carcinoma.
全面分析 KLF2 作为一个与晚期肝细胞癌纤维化和免疫浸润相关的预后生物标志物。
BMC Bioinformatics. 2023 Jun 29;24(1):270. doi: 10.1186/s12859-023-05391-0.
4
Hypomethylation of glycine dehydrogenase promoter in peripheral blood mononuclear cells is a new diagnostic marker of hepatitis B virus-associated hepatocellular carcinoma.外周血单个核细胞中甘氨酸脱氢酶启动子的低甲基化是乙型肝炎病毒相关肝细胞癌的一个新的诊断标志物。
Hepatobiliary Pancreat Dis Int. 2024 Feb;23(1):35-42. doi: 10.1016/j.hbpd.2023.02.011. Epub 2023 Feb 24.
5
Global Epidemiology and Genetics of Hepatocellular Carcinoma.全球肝细胞癌的流行病学和遗传学
Gastroenterology. 2023 Apr;164(5):766-782. doi: 10.1053/j.gastro.2023.01.033. Epub 2023 Feb 2.
6
Clinical heterogeneity of hyperornithinemia-hyperammonemia-homocitrullinuria syndrome in thirteen palestinian patients and report of a novel variant in the gene.13例巴勒斯坦患者高鸟氨酸血症-高氨血症-同型瓜氨酸尿症综合征的临床异质性及该基因新变异的报告
Front Genet. 2022 Nov 24;13:1004598. doi: 10.3389/fgene.2022.1004598. eCollection 2022.
7
Editorial: Bioinformatics tools (and web server) for cancer biomarker development, volume II.社论:用于癌症生物标志物开发的生物信息学工具(及网络服务器),第二卷。
Front Genet. 2022 Oct 10;13:959159. doi: 10.3389/fgene.2022.959159. eCollection 2022.
8
A review of bioinformatics tools and web servers in different microarray platforms used in cancer research.不同癌症研究用微阵列平台中的生物信息学工具和网络服务器综述。
Adv Protein Chem Struct Biol. 2022;131:85-164. doi: 10.1016/bs.apcsb.2022.05.002. Epub 2022 Jun 17.
9
Research progress and prospects of circulating tumor cells in hepatocellular carcinoma.肝细胞癌中循环肿瘤细胞的研究进展与展望
Hepatobiliary Pancreat Dis Int. 2022 Dec;21(6):514-515. doi: 10.1016/j.hbpd.2022.07.001. Epub 2022 Jul 9.
10
HNF4A modulates glucocorticoid action in the liver.HNF4A 调节肝脏中的糖皮质激素作用。
Cell Rep. 2022 Apr 19;39(3):110697. doi: 10.1016/j.celrep.2022.110697.